OVERLAP NON REGR

Inactive Instrument

OVERLAP NON REGR Share Price Euronext Paris

Equities

OVGNR

FR0004051530

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

2013

Aeolus Pharmaceuticals Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended June 30, 2013

CI

Latest news about OVERLAP NON REGR

Aeolus Pharmaceuticals Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended June 30, 2013

14/08/13

CI

Press releases OVERLAP NON REGR

Aeolus Pharmaceuticals Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended June 30, 2013

14/08/13

CI

More press releases

News in other languages on OVERLAP NON REGR

Overlap : accède à la certification Oracle Platinium.	08/06/10
Overlap : premiers effets des mesures de réduction de coûts.	30/11/09
Overlap Groupe : baisse de 3% du CA au T4 08-09.	13/05/09
Overlap Groupe : Alto Invest au-dessus des 5% du capital.	07/04/09
Overlap : devrait dépasser son objectif de CA annuel.	05/02/09

Company Profile

Sector

-

More about the company

Protect and grow your investments with the help of our experts

Secure my Investments

fermer